Deciphering the role of the ERCC2 gene polymorphism on anticancer drug sensitivity

F. Moisan; A. Laroche-Clary; C. Auzanneau; N. Ricard; P. Pourquier; J. Robert; V. Le Morvan

doi:10.1093/carcin/bgs107

Journal Articles Carcinogenesis Year : 2012

Deciphering the role of the ERCC2 gene polymorphism on anticancer drug sensitivity

, , , (1) , (2) , (3) ,

1
2
3

F. Moisan

Function : Author

A. Laroche-Clary

Function : Author

C. Auzanneau

Function : Author

N. Ricard

Function : Author

SOFRADIR (Veurey-Voroize)

P. Pourquier

Function : Author

IDvet [Grabels]

J. Robert

Function : Author

Laboratoire Aimé Cotton

V. Le Morvan

Function : Author

Domains

Life Sciences [q-bio]

Philippe Pourquier : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-02438829

Submitted on : Tuesday, January 14, 2020-1:26:47 PM

Last modification on : Friday, March 24, 2023-2:53:14 PM

Dates and versions

inserm-02438829 , version 1 (14-01-2020)

Identifiers

HAL Id : inserm-02438829 , version 1
DOI : 10.1093/carcin/bgs107

Cite

F. Moisan, A. Laroche-Clary, C. Auzanneau, N. Ricard, P. Pourquier, et al.. Deciphering the role of the ERCC2 gene polymorphism on anticancer drug sensitivity. Carcinogenesis, 2012, 33 (5), pp.962-968. ⟨10.1093/carcin/bgs107⟩. ⟨inserm-02438829⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM CNRS ENS-CACHAN UNIV-PARIS-SACLAY ENS-PARIS-SACLAY GS-PHYSIQUE AIME-COTTON

11 View

0 Download

Deciphering the role of the ERCC2 gene polymorphism on anticancer drug sensitivity

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Altmetric

Share